Back
Coca-Cola FEMSA SAB de CV Vs. Regeneron Pharmaceuticals, Inc. Industry Stock Comparison
Buy
61
KOF
Coca-Cola FEMSA SAB de CV
Last Price:
$96.17
Seasonality Move:
3.06%
Buy
59
REGN
Regeneron Pharmaceuticals, Inc.
Last Price:
$785.06
Seasonality Move:
12.13%
Buy
61
Coca-Cola FEMSA SAB de CV (KOF)
is a Buy
Is Coca-Cola FEMSA SAB de CV a Buy, Sell or Hold?
-
The current Coca-Cola FEMSA SAB de CV [KOF] share price is $96.22. The Score for KOF is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
KOF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Regeneron Pharmaceuticals, Inc. (REGN)
is a Buy
Is Regeneron Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $785.17. The Score for REGN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KOF Stock Price Chart
What is Coca-Cola FEMSA SAB de CV's stock price today?
-
The Coca-Cola FEMSA SAB de CV share price today is $96.22Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KOF is experiencing slight buying pressure.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals, Inc.'s stock price today?
-
The Regeneron Pharmaceuticals, Inc. share price today is $785.17Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing slight buying pressure.
KOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.84 | Buy |
| Relative Strength Index (14 RSI): | 69.46 | Buy |
| Chaikin Money Flow: | 26475 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (87.84 - 93.42) | Buy |
| Bollinger Bands (100): | (83.05 - 89.79) | Buy |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 190.52 | Buy |
| Relative Strength Index (14 RSI): | 67.85 | Buy |
| Chaikin Money Flow: | 31173 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (719.04 - 771.48) | Buy |
| Bollinger Bands (100): | (554.73 - 705.63) | Buy |
KOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 93.69 | Buy |
| 20-day SMA: | 91.4 | Buy |
| 50-day SMA: | 88.59 | Buy |
| 200-day SMA: | 89.56 | Buy |
| 8-day EMA: | 93.83 | Buy |
| 20-day EMA: | 91.95 | Buy |
| 50-day EMA: | 89.48 | Buy |
| 200-day EMA: | 87.99 | Buy |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 758.91 | Buy |
| 20-day SMA: | 747.46 | Buy |
| 50-day SMA: | 686.87 | Buy |
| 200-day SMA: | 601.47 | Buy |
| 8-day EMA: | 551.68 | Buy |
| 20-day EMA: | 302.47 | Buy |
| 50-day EMA: | 139.05 | Buy |
| 200-day EMA: | 37.38 | Buy |
Coca-Cola FEMSA SAB de CV Earnings Growth & KOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.92 per share.
Regeneron Pharmaceuticals, Inc. Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $3.81 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $0.97 per share.
Coca-Cola FEMSA SAB de CV Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||